Baker Ellis Asset Management LLC Vertex Pharmaceuticals Inc Transaction History
Baker Ellis Asset Management LLC
- $658 Million
- Q4 2024
A detailed history of Baker Ellis Asset Management LLC transactions in Vertex Pharmaceuticals Inc stock. As of the latest transaction made, Baker Ellis Asset Management LLC holds 1,058 shares of VRTX stock, worth $512,939. This represents 0.06% of its overall portfolio holdings.
Number of Shares
1,058
Previous 738
43.36%
Holding current value
$512,939
Previous $343,000
24.2%
% of portfolio
0.06%
Previous 0.05%
Shares
4 transactions
Others Institutions Holding VRTX
# of Institutions
1,764Shares Held
222MCall Options Held
1.63MPut Options Held
1.47M-
Capital World Investors Los Angeles, CA28.3MShares$13.7 Billion1.8% of portfolio
-
Vanguard Group Inc Valley Forge, PA23.3MShares$11.3 Billion0.17% of portfolio
-
Black Rock Inc. New York, NY21.3MShares$10.3 Billion0.23% of portfolio
-
State Street Corp Boston, MA12MShares$5.81 Billion0.2% of portfolio
-
Capital Research Global Investors Los Angeles, CA10.4MShares$5.06 Billion0.9% of portfolio
About VERTEX PHARMACEUTICALS INC
- Ticker VRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 256,691,008
- Market Cap $124B
- Description
- Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...